Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.60
-0.07 (-1.91%)
At close: Aug 15, 2025, 10:20 AM

Oncology Institute Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
49.67M 33.49M 14.01M 114.3M
Short-Term Investments
n/a 49.37M 59.8M n/a
Long-Term Investments
n/a n/a 58.35M -371K
Other Long-Term Assets
589K 561K 369K 320K
Receivables
48.68M 42.91M 40.43M 21.24M
Inventory
10.04M 13.68M 9.26M 6.44M
Other Current Assets
4.03M n/a 88K 875K
Total Current Assets
112.42M 143.49M 130.51M 154.06M
Property-Plant & Equipment
37.67M 40.05M 33.04M 4.19M
Goodwill & Intangibles
22.04M 25.13M 41.37M 44.87M
Total Long-Term Assets
60.3M 65.75M 133.24M 49.38M
Total Assets
172.72M 209.24M 263.75M 203.44M
Account Payables
24.32M 14.43M 9.37M 15.56M
Deferred Revenue
4.7M 545K 1.14M 592K
Short-Term Debt
n/a n/a n/a 183K
Other Current Liabilities
10.35M 11.32M 9.48M 10.14M
Total Current Liabilities
52.22M 34.79M 29.85M 29.8M
Long-Term Debt
93.13M 86.83M 80.62M n/a
Other Long-Term Liabilities
527K 4.08M 5.79M 69.11M
Total Long-Term Liabilities
116.91M 117.43M 109.22M 69.48M
Total Liabilities
169.13M 152.22M 139.07M 99.28M
Total Debt
123.15M 119.67M 108.18M 183K
Common Stock
8K 8K 7K 7K
Retained Earnings
-210.81M -146.15M -61.58M -63.23M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
3.59M 57.02M 124.68M 104.16M
Total Investments
n/a 49.37M 118.15M -371K